T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results
06 juil. 2022 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems to Appear on the Benzinga All Access Show on June 17, 2022
15 juin 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market
10 juin 2022 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Issuance of U.S. Patent for Direct Detection of Lyme Disease
20 mai 2022 09h17 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the...
T2 Biosystems Announces First Quarter 2022 Financial Results
05 mai 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Receipt of Nasdaq Delisting Notice
05 mai 2022 16h02 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Formation and Members of Scientific Advisory Board
28 avr. 2022 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
27 avr. 2022 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems to Report First Quarter 2022 Financial Results on May 5, 2022
21 avr. 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Reports Granting of Inducement Award
14 avr. 2022 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards...